Cmc And Spike Human
Lab Reagents
Human IgG antibody Laboratories manufactures the cmc and spike human reagents distributed by Genprice. The Cmc And Spike Human reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Human. Other Cmc products are available in stock. Specificity: Cmc Category: And Group: Spike Human
SARS Spike Antibody |
|||
24318-100ul | SAB | 100ul | EUR 468 |
SARS Spike Peptide |
|||
3525P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) SARS Spike peptide |
SARS Spike Antibody |
|||
20-abx137184 | Abbexa |
|
|
SARS Spike Antibody |
|||
20-abx137200 | Abbexa |
|
|
Spike Glycoprotein Antibody |
|||
20-abx300551 | Abbexa |
|
|
Acids Matrix Spike |
|||
CLPS-MSA | Scientific Laboratory Supplies | 1ML | EUR 120.84 |
TCLP Volatiles Spike |
|||
TCLP-VX | Scientific Laboratory Supplies | 1ML | EUR 106.02 |
CLP ILM 02.0 |
|||
SPIKE-1 | Scientific Laboratory Supplies | 125ML | EUR 303.24 |
Human coronavirus OC43 Spike glycoprotein (S) |
|||
1-CSB-YP336163HIY | Cusabio |
|
|
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in Yeast |
Human coronavirus OC43 Spike glycoprotein (S) |
|||
1-CSB-EP336163HIY | Cusabio |
|
|
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in E.coli |
Recombinant SARS-CoV-2 Spike S1 Protein with hFc and His-Tag |
|||
E80001-1 | EpiGentek | 100 ul | EUR 518.1 |
Recombinant SARS-CoV-2 Spike S1 Protein with His and Avi Tag |
|||
E80003-1 | EpiGentek | 100 ul | EUR 518.1 |
SARS-CoV Spike Antibody |
|||
3219-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3219-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3221-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3221-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS (IN1) Spike Peptide |
|||
3221P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN1) Spike peptide |